Literature DB >> 2453373

Effect of recombinant and purified hematopoietic growth factors on human megakaryocyte colony formation.

E Bruno1, R Briddell, R Hoffman.   

Abstract

The effect of a number of purified or recombinant hematopoietic growth factors, including recombinant erythropoietin (rEpo), thrombocytopoiesis stimulating factor (TSF), recombinant interleukin 1 alpha (rIL-1 alpha), recombinant granulocyte colony-stimulating factor (rG-CSF), macrophage colony-stimulating factor (CSF-1), recombinant interleukin 3 (rIL-3), and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF), on megakaryocyte (MK) colony formation by normal human marrow cells in a serum-depleted assay system was determined. Neither rEpo, TSF, CSF-1, rIL-1 alpha, nor rG-CSF alone augmented MK colony formation. Both rGM-CSF and rIL-3 at optimal doses increased MK colony formation eightfold and tenfold, respectively, above baseline values. Addition of increasing amounts of either rGM-CSF or rIL-3 led to progressively greater numbers of MK colonies formed until plateau levels were reached. Both rGM-CSF and rIL-3 also led to a dose-related increase in the number of cells per MK colony formed in culture. These molecules were equivalent stimulators of MK colony formation when their effects at optimal concentrations were compared. The effects of rGM-CSF and rIL-3 were additive at suboptimal concentrations of rIL-3 in that colony formation by a combination of the two growth factors approximated the sum of colony formation by each growth factor alone. These data suggest that rGM-CSF and rIL-3 alone and in combination are important regulators of in vitro megakaryocytopoiesis at the progenitor cell level.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453373

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  8 in total

1.  Manipulations of cholinesterase gene expression modulate murine megakaryocytopoiesis in vitro.

Authors:  D Patinkin; S Seidman; F Eckstein; F Benseler; H Zakut; H Soreq
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  Macrophages prevent human red blood cell reconstitution in immunodeficient mice.

Authors:  Zheng Hu; Nico Van Rooijen; Yong-Guang Yang
Journal:  Blood       Date:  2011-09-16       Impact factor: 22.113

3.  Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow.

Authors:  J Brandt; E F Srour; K van Besien; R A Briddell; R Hoffman
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

4.  Acute in vivo effects of IL-3 alone and in combination with IL-6 on the blood cells of the circulation and bone marrow.

Authors:  T R Ulich; J del Castillo; K Busser; K Z Guo; S M Yin
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

5.  Lineage-unrestricted hematologic response to granulocyte colony-stimulating factor in a patient with refractory anemia with excess blasts.

Authors:  N Yokose; K Ogata; E An; H Tamura; K Kamikubo; K Dan; T Nomura
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673

6.  Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study.

Authors:  G J Veldhuis; P H Willemse; J H Beijnen; H Boonstra; H Piersma; W T van der Graaf; E G de Vries
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 7.  Numerous growth factors can influence in vitro megakaryocytopoiesis.

Authors:  R Hoffman; R Briddell; E Bruno
Journal:  Yale J Biol Med       Date:  1990 Sep-Oct

8.  Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.

Authors:  M W Dercksen; K Hoekman; W W ten Bokkel Huinink; E M Rankin; R Dubbelman; H van Tinteren; J Wagstaff; H M Pinedo
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.